Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SG 001 - ADMA Biologics

Next Previous
Drug Profile

SG 001 - ADMA Biologics

Alternative Names: Anti-pneumococcal immune globulin - ADMA Biologics; S pneumonia immune globulin - ADMA Biologics; S. pneumonia hyperimmune globulin - ADMA Biologics; SG-001 - ADMA Biologics; Streptococcus pneumonia immune globulin - ADMA Biologics

Latest Information Update: 14 Nov 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ADMA Biologics
  • Class Antibacterials; Immunoglobulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Pneumococcal infections

Most Recent Events

  • 05 Nov 2025 ADMA Biologics submits Commissioner’s National Priority Voucher (CNPV) application to the US FDA for SG 001
  • 08 Jan 2024 ADMA Biologic has patent protection for the compositions and methods of manufacturing, and methods of using the S. pneumonia hyperimmune globulin for the treatment of Pneumococcal infections in USA and Europe
  • 08 Jan 2024 Preclinical trials in Pneumococcal infections in USA (Parenteral)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top